We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$407M
AUM Growth
-$38.3M
Cap. Flow
-$52.4M
Cap. Flow %
-12.88%
Top 10 Hldgs %
19.3%
Holding
282
New
19
Increased
67
Reduced
110
Closed
63

Top Buys

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$6.14M
2
ADAP
Adaptimmune Therapeutics
ADAP
+$5.93M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$5.36M
4
ALBO
Albireo Pharma Inc
ALBO
+$1.07M
5
ZYME icon
Zymeworks
ZYME
+$808K

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$8.83M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.78M
3
LJPC
La Jolla Pharmaceutical Company
LJPC
+$4.57M
4
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$1.53M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$966K

Sector Composition

Rank Sector Weight
1 Industrials 19.96%
2 Technology 18%
3 Healthcare 15.75%
4 Materials 7.84%
5 Financials 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBPX
76
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$1.56M 0.38%
41,619
+2,259
+6% +$80.3K
T icon
77
AT&T
T
$152B
$1.56M 0.38%
61,475
-9,799
-14% -$240K
UNH icon
78
UnitedHealth
UNH
$387B
$1.52M 0.37%
5,712
-1
-0% -$260
TPIC
79
DELISTED
TPI Composites
TPIC
$1.48M 0.36%
51,726
+1,521
+3% +$44K
BUD icon
80
AB InBev
BUD
$156B
$1.48M 0.36%
16,851
-345
-2% -$33.6K
MWA icon
81
Mueller Water Products
MWA
$3.98B
$1.44M 0.35%
124,816
+3,818
+3% +$45.2K
SLP icon
82
Simulations Plus
SLP
$369M
$1.43M 0.35%
70,613
+2,028
+3% +$39.6K
MET icon
83
MetLife
MET
$60.5B
$1.37M 0.34%
29,344
-308
-1% -$14.1K
GOOGL icon
84
Alphabet (Google) Class A
GOOGL
$4.23T
$1.28M 0.32%
21,280
+520
+3% +$31.5K
NEE icon
85
NextEra Energy
NEE
$185B
$1.28M 0.32%
30,608
+284
+0.9% +$12.1K
ADM icon
86
Archer Daniels Midland
ADM
$41.4B
$1.27M 0.31%
25,241
+838
+3% +$41.1K
KHC icon
87
Kraft Heinz
KHC
$30.7B
$1.25M 0.31%
22,736
-1,123
-5% -$67.1K
RTN
88
DELISTED
Raytheon Company
RTN
$1.18M 0.29%
5,694
-110
-2% -$21.9K
LUV icon
89
Southwest Airlines
LUV
$23.5B
$1.18M 0.29%
18,832
+117
+0.6% +$6.84K
DIS icon
90
Walt Disney
DIS
$170B
$1.17M 0.29%
10,032
+103
+1% +$11.5K
MPC icon
91
Marathon Petroleum
MPC
$91.3B
$1.17M 0.29%
14,660
+617
+4% +$48.8K
ECOL
92
DELISTED
US Ecology, Inc.
ECOL
$1.17M 0.29%
15,811
+514
+3% +$36.2K
NOC icon
93
Northrop Grumman
NOC
$74.1B
$1.17M 0.29%
3,670
-73
-2% -$22.2K
KLAC icon
94
KLA
KLAC
$278B
$1.16M 0.28%
113,900
+2,480
+2% +$27.1K
WTRG icon
95
Essential Utilities
WTRG
$11.3B
$1.16M 0.28%
31,358
+414
+1% +$15.3K
VTR icon
96
Ventas
VTR
$46.7B
$1.15M 0.28%
21,149
-159
-0.7% -$9.21K
KLIC icon
97
Kulicke & Soffa
KLIC
$5.09B
$1.13M 0.28%
47,562
+1,347
+3% +$34.9K
HDS
98
DELISTED
HD Supply Holdings, Inc.
HDS
$1.13M 0.28%
26,430
+174
+0.7% +$7.62K
MDT icon
99
Medtronic
MDT
$106B
$1.13M 0.28%
11,436
+180
+2% +$16.6K
VLO icon
100
Valero Energy
VLO
$91.9B
$1.12M 0.28%
9,851
+102
+1% +$11.6K
2 3
4
5 6

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q3 2018 Portfolio in Review

As of Q3 2018, Stanley-Laman Group held 282 positions worth $407M, down 8.6% from $445M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Stanley-Laman Group withdrew a net $52.4M in Q3 2018, closing 63 positions and reducing 110 holdings. Its most notable exit was Neurocrine Biosciences, an estimated $8.83M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Stanley-Laman Group opened a new position in Acceleron Pharma worth $7.16M.

  • Stanley-Laman Group's largest Q3 2018 buy was Acceleron Pharma: 125,020 shares worth $7.16M.
  • Stanley-Laman Group added most to Prudential Financial in Q3 2018, an estimated $152K increase.
  • Stanley-Laman Group's biggest Q3 2018 reduction was Hortonworks, Inc., cutting an estimated $629K.
  • Stanley-Laman Group fully exited Neurocrine Biosciences in Q3 2018, selling an estimated $8.83M.
  • Stanley-Laman Group's ten largest holdings make up 19% of its $407M portfolio in Q3 2018.
  • Stanley-Laman Group opened 19 new positions and closed 63 in Q3 2018.
  • Stanley-Laman Group's portfolio value fell 8.6% quarter-over-quarter to $407M.

Based on Stanley-Laman Group's 13F filing for Q3 2018, filed 30 Oct 2018.